{"entity":{"id":"nct07795034","kind":"trial","name":"To Evaluate the Efficacy and Safety of Accelerator-Based Boron Neutron Capture Therapy (AB-BNCT) Combined With NBB-001 and NBB-002 for Patients With Recurrent Head and Neck Malignancies","aka":[],"tldr":"A phase 2 trial of Boron Neutron Capture Therapy in head and neck squamous cell carcinoma, run by Neuboron Bio-SciTech Co., Ltd., now recruiting.","summary":"To Evaluate the Efficacy and Safety of Accelerator-Based Boron Neutron Capture Therapy (AB-BNCT) Combined With NBB-001 and NBB-002 for Patients With Recurrent Head and Neck Malignancies is a phase 2 interventional study registered as NCT07795034 by Neuboron Bio-SciTech Co., Ltd., with 35 participants planned, started 2026-08-31 and due to reach its primary completion in 2027-08. Interventions recorded: Boron Neutron Capture Therapy.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT07795034","url":"https://clinicaltrials.gov/study/NCT07795034"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["head-and-neck","recurrent-metastatic-hnscc"],"sections":[],"technologies":["bnct"],"targets":[],"drugs":[],"companies":["neuboron-medtech"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07795034","phase":"2","setting":"A Single-Arm, Open-Label Phase II Clinical Trial to Evaluate the Efficacy and Safety of Accelerator-Based Boron Neutron Capture Therapy (AB-BNCT) Combined With NBB-001 and NBB-002 for Patients With Recurrent Head and Neck Malignancies","sponsor":"Neuboron Bio-SciTech Co., Ltd.","participation":[{"nct":"NCT07795034","source":"https://clinicaltrials.gov/study/NCT07795034","fetchedAt":"2026-10-07T16:56:51.027Z","studySha256":"15a1a461fd8e68a09313bd3eccfa0f0abef23a932899f211ec0f24b6c1291f49","overallStatus":"RECRUITING","lastUpdatePosted":"2026-09-08","leadSponsor":"Neuboron Bio-SciTech Co., Ltd.","collaboratorCount":0,"minimumAge":"18 Years","maximumAge":"75 Years","sex":"ALL","healthyVolunteers":false,"hasEligibility":true,"enrolment":35,"enrolmentType":"ESTIMATED","siteCount":1,"recruitingSiteCount":1,"countries":["China"]}],"started":"2026-08-31","startedType":"estimated","enrolled":35,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07795034/","neighbours":{"cancer":[{"id":"head-and-neck","kind":"cancer","name":"Head and neck squamous cell carcinoma","route":"/cancers/head-and-neck/"},{"id":"recurrent-metastatic-hnscc","kind":"cancer","name":"Recurrent or metastatic head and neck squamous cell carcinoma","route":"/cancers/recurrent-metastatic-hnscc/"}],"technology":[{"id":"bnct","kind":"technology","name":"Boron neutron capture therapy","route":"/technologies/bnct/"}],"company":[{"id":"neuboron-medtech","kind":"company","name":"Neuboron Medtech","route":"/companies/neuboron-medtech/"}]}}